LifeScience Clinical & Diagnostic
Shanghai Ark Biopharmaceutical Secures NMPA Approval For Azstarys ADHD Treatment In China
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that China's National Medical Products Administration (NMPA) has approved the New D...
January 07, 2026 | News
ScinoPharm Taiwan Becomes First In Country To Secure US FDA Approval For Multiple Sclerosis Injection
ScinoPharm Taiwan announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Gl...
January 06, 2026 | News
UltraGreen Secures Dual Regulatory Approvals In Southeast Asia
UltraGreen has obtained regulatory approvals for both its Verdye in the Philippines and its IC-Flow™ Imaging System V2 in Malaysia ...
December 31, 2025 | News
Alphamab Oncology Secures IND Acceptance In China For JSKN033 Phase II Cervical Cancer Study
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcu...
December 30, 2025 | News
Sobi Secures Positive CHMP Opinion For Aspaveli In Rare Kidney Diseases
Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN If approved, Aspaveli (pegcetacoplan) would be the first C3G and primary IC-...
December 30, 2025 | News
Japan Approves Sephience For All Ages Marking First PTC Product Clearance In The Country
– Indication includes all ages and the full spectrum of disease severity –– First Japan product approval for PTC – PTC T...
December 30, 2025 | News
Niowave Extends Actinium 225 Supply Agreement With AstraZeneca To Support Next Generation Cancer Therapies
Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca 10-year supply agreement ...
December 29, 2025 | News
HKSH Medical Group And Shenzhen Cancer Hospital Formalise Proton Therapy Collaboration Under Healthy China 2030 Framework
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH")...
December 25, 2025 | News
NeuroSense Reports Clean Safety Profile From Phase 2 PrimeC Study In Alzheimer’s Disease
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for&nbs...
December 24, 2025 | News
Ginkgo Bioworks Joins Carnegie Mellon Led ARPA H Programme To Advance At Home Cancer Detection
Ginkgo Bioworks announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects Agency for Health...
December 24, 2025 | News
Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...
December 23, 2025 | News
Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer
Incyte Biosciences Japan G.K. announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination w...
December 23, 2025 | News
Merck Secures World First Regulatory Approval For Pimicotinib In Rare Joint Tumour TGCT In China
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantl...
December 23, 2025 | News
Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation
-Meiji Seika Pharma Co., Ltd. announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...
December 22, 2025 | News
Most Read
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
